Total Payments
$11,285
2024 Payments
$1,122
Companies
48
Transactions
346
Medicare Patients
7,432
Medicare Billing
$559,434
Payment Breakdown by Category
Food & Beverage$8,898 (78.8%)
Travel$2,107 (18.7%)
Education$280.37 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,898 | 326 | 78.8% |
| Travel and Lodging | $2,107 | 7 | 18.7% |
| Education | $280.37 | 13 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $3,043 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $1,757 | 80 | $0 (2022) |
| SRS Medical Systems, Inc. | $508.41 | 3 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $432.02 | 10 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $416.94 | 19 | $0 (2024) |
| PFIZER INC. | $407.23 | 24 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $393.22 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $267.41 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $263.30 | 8 | $0 (2023) |
| Myovant Sciences Inc. | $242.88 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,122 | 28 | SRS Medical Systems, Inc. ($234.23) |
| 2023 | $1,366 | 42 | Sumitomo Pharma America, Inc. ($249.66) |
| 2022 | $2,600 | 46 | Axonics, Inc. ($1,662) |
| 2021 | $2,331 | 56 | Axonics, Inc. ($1,306) |
| 2020 | $540.47 | 29 | Astellas Pharma US Inc ($252.76) |
| 2019 | $676.70 | 34 | Astellas Pharma US Inc ($236.60) |
| 2018 | $1,608 | 69 | Astellas Pharma US Inc ($629.42) |
| 2017 | $1,042 | 42 | Astellas Pharma US Inc ($298.83) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: HORMONE THERAPY | ||||||
| 11/26/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Prostate cancer | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | SRS Medical Systems, Inc. | CT3000 Pro Base Unit (Device), UroCuff-DC Disposable, Single | Food and Beverage | Cash or cash equivalent | $234.23 | General |
| Category: Urology | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: HORMONE THERAPY | ||||||
| 11/04/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $77.65 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: HORMONE THERAPY | ||||||
| 09/16/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Urology Gynecology | ||||||
| 08/27/2024 | Boston Scientific Corporation | Lynx System (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Lynx_URO | ||||||
| 08/22/2024 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Food and Beverage | Cash or cash equivalent | $139.32 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 08/22/2024 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $37.52 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $44.27 | General |
| Category: Urology | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Oncology | ||||||
| 05/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: HORMONE THERAPY | ||||||
| 04/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: HORMONE THERAPY | ||||||
| 03/20/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Men's Health | ||||||
| 03/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $100.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,896 | 2,855 | $716,077 | $162,610 |
| 2022 | 27 | 1,687 | 2,465 | $562,346 | $136,776 |
| 2021 | 29 | 1,839 | 2,525 | $526,975 | $130,127 |
| 2020 | 33 | 2,010 | 2,794 | $570,104 | $129,921 |
Total Patients
7,432
Total Services
10,639
Medicare Billing
$559,434
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 576 | $134,208 | $52,102 | 38.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 226 | $217,864 | $29,859 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 236 | $38,940 | $15,227 | 39.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 69 | 70 | $28,618 | $15,096 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $31,850 | $10,626 | 33.4% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 18 | 18 | $39,312 | $5,036 | 12.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 172 | 275 | $29,975 | $4,956 | 16.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 31 | 32 | $52,768 | $4,809 | 9.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 77 | 83 | $57,768 | $4,799 | 8.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 50 | 50 | $12,767 | $4,299 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $4,920 | $2,792 | 56.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 34 | 103 | $5,974 | $2,759 | 46.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 36 | $4,896 | $2,239 | 45.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 453 | 751 | $16,391 | $1,652 | 10.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,338 | $1,327 | 30.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 19 | 19 | $2,261 | $1,243 | 55.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 22 | $4,070 | $815.41 | 20.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 50 | 50 | $11,568 | $807.92 | 7.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 62 | 72 | $5,616 | $602.79 | 10.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 14 | 16 | $1,776 | $404.64 | 22.8% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 14 | 16 | $1,344 | $399.36 | 29.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 14 | 16 | $880.00 | $340.80 | 38.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 47 | 48 | $7,005 | $208.88 | 3.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $968.00 | $208.12 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 344 | 495 | $93,859 | $44,614 | 47.5% |
About Dr. Lambda Msezane, M.D
Dr. Lambda Msezane, M.D is a Urology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306092184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lambda Msezane, M.D has received a total of $11,285 in payments from pharmaceutical and medical device companies, with $1,122 received in 2024. These payments were reported across 346 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,898).
As a Medicare-enrolled provider, Msezane has provided services to 7,432 Medicare beneficiaries, totaling 10,639 services with total Medicare billing of $559,434. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Decatur, GA
- Active Since 08/13/2008
- Last Updated 03/07/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1306092184
Products in Payments
- XTANDI (Drug) $1,352
- Axonics r-SNM System (Device) $1,278
- Bulkamid (Device) $1,034
- Axonics (Device) $802.26
- ORGOVYX (Drug) $473.44
- PROVENGE (Drug) $432.02
- GEMTESA (Drug) $417.98
- MYRBETRIQ (Drug) $396.11
- PROLARIS (Device) $249.52
- CT3000 Pro Base Unit (Device) $234.23
- Xofigo (Drug) $213.30
- UROLIFT (Device) $211.65
- INTERSTIM (Device) $205.56
- KEYTRUDA (Biological) $202.91
- Erleada (Drug) $181.43
- XIAFLEX (Biological) $175.05
- eCoin Device Kit (Device) $156.21
- UroCuff (Device) $154.16
- Myrbetriq (Drug) $150.46
- CAMCEVI (Drug) $148.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Decatur
Daniel Canter, Md, MD
Urology — Payments: $328,478
Urology $328,478
Dr. Michael Kemper, M.d, M.D
Urology — Payments: $76,978
Urology $76,978
Dr. Syed Jafri, M.d, M.D
Urology — Payments: $16,394
Urology $16,394
Dr. Sergey Ananyev, M.d, M.D
Urology — Payments: $12,352
Urology $12,352
Walter Falconer, M.d, M.D
Urology — Payments: $12,271
Urology $12,271
William Hughes, Md, MD
Urology — Payments: $6,822
Urology $6,822